Henneicke-von Zepelin H, Hentschel C, Schnitker J, et al. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study.
Curr Med Res Opin. 2000;15:214–27.
Wustenberg P, Henneicke-von Zepelin HH, Kohler G, et al. Efficacy and mode of action of an immunomodulator herbal preparation containing
Echinacea, wild indigo, and white cedar.
Adv Ther. 1999;16:51–70.
Hauke W, Kohler G, Henneicke-Von Zepelin HH, et al. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study.
Chemotherapy. 2002;48:259–66.
Egert D, Beuscher N. Studies on antigen specifity of immunoreactive arabinogalactan proteins extracted from
Baptisia tinctoria
and
Echinacea purpurea.
Planta Med. 1992;58:163–5.
Wagner H, Jurcic K. Immunologic studies of plant combination preparations. In-vitro and in-vivo studies on the stimulation of phagocytosis [in German].
Arzneimittelforschung. 1992;41:1072–6.
Beuscher N, Scheit KH, Bodinet C, et al. Immunologically active glycoproteins of
Baptisia tinctoria
[in German].
Planta Med. 1989;55:358–63.
Naser B, Lund B, Henneicke-von Zepelin HH, et al. A randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common cold.
Phytomedicine. 2005;12:715-22.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.